Bryan Marsh
marshbp.bsky.social
Bryan Marsh
@marshbp.bsky.social
Postdoc at Genentech interested cell identity, TFs, and oncology | PhD at UCSF working on the placental development




Reposted by Bryan Marsh
few outcomes, except for 99% of FDA-approved drugs, 174 recipients of 104 Nobel Prizes, training ~30K MDs and ~10K PhDs per year to enter the workforce, and a 34% reduction in age-adjusted cancer deaths since 1990 -- the largest decrease in history
Now do the Department of Defense budget, Andrew.

“Washington has thrown billions at NIH for decades with little accountability and few measurable outcomes,” HHS spokesperson Andrew Nixon said in a statement to Future Pulse.

www.politico.com/newsletters/...
NIH spending battle’s ripple effect
www.politico.com
July 29, 2025 at 3:26 AM
Reposted by Bryan Marsh
🚨 New Paper Alert! 🚨
Our latest study on KMT2C/KMT2D (mutated in 20% of cancers) reveals a new function for H3K4me1 in regulating DNA replication timing (RT) and origin activity during cell state transitions. Check it out: www.cell.com/cell-reports.... More info ⬇️
KMT2C/KMT2D-dependent H3K4me1 mediates changes in DNA replication timing and origin activity during a cell fate transition
Gökbuget et al. use machine learning to quantify chromatin state changes that predict DNA replication timing changes during cell differentiation. By following up on top predictors through functional v...
www.cell.com
February 4, 2025 at 5:06 PM